Kainova Therapeutics
Kainova Therapeutics, formerly Domain Therapeutics, is a clinical-stage biopharmaceutical company developing GPCR-modulating therapies for immuno-oncology and inflammatory diseases. Its pipeline includes small-molecule and antibody programs targeting EP4, CCR8 and PAR2, supported by a proprietary drug discovery platform.
Key facts
| Also Known As | DOMAIN Therapeutics |
|---|---|
| Legal Name | DOMAIN THERAPEUTICS |
| Company Operating Status | Active |
| Full Address | 7171 Frederick Banting, Montreal, Quebec H4S 1Z9, Canada |
| Wellfound ID | domain-therapeutics |
| Wikidata ID | Q30287121 |
Contact details
Email and phone for Kainova Therapeutics are available to signed-in members of CliffBio.
Sign in to view